Free the Data!
Please consider submitting BRCA1/2 testing results from your patients to www.sharingclinicalreports.org.
See: http://nyti.ms/14hUJsu for an explanation of the issue.
Thank you, Your GeneDx Team

CDKN2A (p16) Gene Sequencing

FORMS AND DOCUMENTS

• Test Info Sheet
• Test Requisition
• Informed Consent

TEST DETAILS

Genes:

CDKN2A

Disorders:

• Familial Cutaneous Malignant Melanoma
• Familial Multiple Mole and Melanoma Syndrome

Clinical Utility:

• Identification of a hereditary susceptibility to melanoma
• Development of a clinical surveillance plan to detect suspicious lesions early
• Identification of at-risk family members
• Prenatal diagnosis

Lab Method:

Capillary Sequencing

ORDERING

Test Code:

2022

Turnaround Time:

4-6 weeks

Preferred Specimen:

2-5 mL Blood - Lavender Top Tube

BILLING

CPT Codes:

81404x1

List Price:

$660.00

Billing Information:

View Billing Policy

ICD Codes:

• 172.9: Melanoma of skin, site unspecified

REFERENCES

1. Hayward NK (2003) Oncogene 22:3053-3062
2. Goldstein et al., (2006) Cancer Res 66:9818-9828
3. Berwick et al., (2006) Cancer Epidemiolo Biomarkers Prev 15: 1520-1525
4. Lesueur et al., (2008) Brit J of Cancer 99:364-370
5. Helsing et al., (2008) Genes Chromosomes & Cancer 47:175-184
6. Vignoli et al., (2008) Melanoma Research 18:431-437

Back To Top